Stage-Specific Transcriptome Landscape of Hepatocellular Carcinoma: Insights From Super and Poor Survivors With Prognostic Signature Identification
- Xiao Qian Xu 1,2, Hao Wang 1,2, Li Chen Shi 1,2, Cheng Huang 1,2, Hong You 3, Ji Dong Jia 3, You Wen He 4, Yuan Yuan Kong 1,2
- Xiao Qian Xu 1,2, Hao Wang 1,2, Li Chen Shi 1,2
- 1National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
- 2Clinical Epidemiology and EBM Unit, Beijing Clinical Research Institute, Beijing, China.
- 3National Clinical Research Center for Digestive Diseases, Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
- 4Department of Integrative Immunobiology, Duke University School of Medicine, Durham, North Carolina, USA.
- 0National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A novel 19-gene signature accurately predicts survival in hepatocellular carcinoma (HCC) patients by analyzing transcriptomic differences between super and poor survivors. This signature aids in personalized prognosis for HCC.
Area Of Science
- Oncology
- Genomics
- Transcriptomics
Background
- Hepatocellular carcinoma (HCC) prognosis varies widely, even within the same clinical stage.
- Identifying molecular markers for patient survival is crucial for personalized treatment.
Purpose Of The Study
- To characterize the stage-specific transcriptomic landscape in HCC super survivors.
- To develop a prognostic gene signature for predicting HCC patient survival.
Main Methods
- Analysis of The Cancer Genome Atlas (TCGA) data from HCC patients.
- Gene set enrichment analysis stratified by tumor stage.
- Development and validation of a 19-gene signature using TCGA and International Cancer Genome Consortium (ICGC) cohorts.
Main Results
- Stage-specific transcriptomic differences were observed in immune response, catabolic activities, and glycolysis.
- Super survivors exhibited less active cell cycle processes across all stages.
- The 19-gene signature achieved 90.8% accuracy in distinguishing super from poor survivors and showed reliable survival prediction in validation cohorts.
Conclusions
- A 19-gene signature, reflecting dynamic shifts during HCC progression, can accurately predict patient survival.
- This signature holds potential as a tool for personalized prognosis in HCC.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:39
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
01:05
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

